Halsin Partners (@Halsin) header
Halsin Partners (@Halsin) profile picture

Full service communications consultancy servicing biotech, medical device and diagnostic companies.

London, United Kingdom
Joined June 2009
Photo by Halsin Partners (@Halsin)Photo by Halsin Partners (@Halsin)Photo by Halsin Partners (@Halsin)Photo by Halsin Partners (@Halsin)Photo by Halsin Partners (@Halsin)Photo by Halsin Partners (@Halsin)Photo by Halsin Partners (@Halsin)Photo by Halsin Partners (@Halsin)Photo by Halsin Partners (@Halsin)Photo by Halsin Partners (@Halsin)
Halsin Partners retweeted
Kurma Partners closes Biofund IV at €215M, giving European biotech a fresh specialist pool of capital european-biotechnology.com/l… Kurma Partners has closed Biofund IV at €215 million, giving European biotech founders a meaningful new source of capital even though the vehicle...
1
40
Just out in @NatureBiotech - a deep dive into what's next in idiopathic pulmonary fibrosis after the approval of @Boehringer 's Jascayd (nerandomilast). There's still huge scope for innovation here - & many good ideas being pursued. nature.com/articles/s41587-0…
3
9
4,619
The French biotech startup EG 427 has made a gene therpay based on a herpesvirus vector that delivers a botulinum toxin to sensory neurons to reduce urinary incontinence by 88% in spinal cord injury patients. Read more in my exclusive for @endpts - endpoints.news/exclusive-fre…
1
283
The Dementia Disparity: Rethinking Alzheimer’s Through The Female Lens — Click the image below to read more! || #InVivo | Start your free trial today: vist.ly/43pj6 vist.ly/43pj7
1
37
Podcast: Scancell’s Cancer Vaccine Progress With NHS Partnership — Click the image below to read more! || #InVivo | Start your free trial today: vist.ly/3yqbe vist.ly/3yqbf
1
1
35
We are excited to lead a CHF2 million investment in @stalicla_sa , a fellow clinical-stage Swiss biotech focused on precision medicine for neurodevelopmental and neuropsychiatric disorders. This strategic investment supports our commitment to advancing innovative treatments
1
1
1
192
On Saturday, Mikhail Kalinichev, our Head of Translational Science will present the progress we’ve made in our GABAB PAM cough program at the 10th American Cough Conference.
1
1
1
80
In Brief: Bioxodes To Take Novel Hemorrhagic Stroke Drug Into Registrational Trial ow.ly/oRJC1066QYw #PharmaScrip
1
116
Tomorrow we will issue our Full-Year 2024 Financial Results. Our CEO, Tim Dyer, and Mikhail Kalinichev, Head of Translational Science, will host a conference call and webcast at 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) to discuss the results and provide a corporate update.
1
1
1
63
On World Parkinson’s Day, we recognize all the individuals, their families, and caregivers who are all impacted significantly by this debilitating disease. #Parkinson’s disease is a progressive and debilitating neurological disorder affecting millions of people worldwide.
1
1
1
62
New study demonstrates benefit of Neo Medical’s spine surgery tech Neo Medical’s Force Control technology has proven to reduce implant-related revision surgeries by 58%. medicaldevice-network.com/ne…
1
1
46
Join us in Chicago at the American Association for Cancer Research (AACR) Annual Meeting 2025, from April 25-30! 👉investors.molecularpartners.… #Cancer #Oncology #AACR2025 #DARPin #RadioDARPin
1
118
Halsin Partners retweeted
Could spray-dried RNA vaccines formulated for nasal administration be the key to unlocking access to RNA-based vaccines? 🔓💉 CEPI is providing $5 million to @ethris_mRNA to find out. Learn more ⬇️ cepi.net/cepi-partners-ethri…
3
9
691
Alithea Genomics Launches Full-Length DRUG-Seq to Unlock Full Power of Transcriptomics for Drug Discovery dlvr.it/TGd8Pv
1
49